19^th World Drug Delivery Summit

Welcome Message

It is our great pleasure to welcome you to the 19th World Drug Delivery Summit, taking place on January 29–30, 2026, in Paris, France. This prestigious gathering brings together leading scientists, researchers, clinicians, industry experts, and innovators from around the world to explore the latest advances shaping the future of drug delivery science and technology.

Over the next two days, we will delve into emerging platforms, novel therapeutics, translational research, and cutting-edge delivery systems designed to improve efficacy, safety, and patient outcomes. Through keynote presentations, interactive sessions, panel discussions, and collaborative networking opportunities, we hope to inspire new ideas, forge meaningful partnerships, and accelerate the path from discovery to clinical impact.

Paris—renowned for its rich scientific heritage, cultural vibrancy, and timeless charm—provides the perfect backdrop for this international exchange of knowledge and innovation.

We extend our warmest welcome to all participants and look forward to a productive, inspiring, and memorable Summit.

Welcome to Paris, and welcome to the 19th World Drug Delivery Summit 2026!

About Conference

The 19th World Drug Delivery Summit is an international gathering of researchers, scientists, pharmaceutical professionals, and industry leaders focused on the latest innovations in drug delivery and pharmaceutical formulations. The conference aims to provide a global platform for sharing knowledge, discussing recent developments, and exploring future trends in drug delivery technologies.

Key topics include advanced drug delivery systems, targeted therapies, nanomedicine, controlled and sustained release formulations, mRNA and gene therapy delivery, personalized medicine, and smart drug delivery platforms. Attendees will have the opportunity to engage in scientific sessions, poster presentations, workshops, and panel discussions led by renowned experts from academia and industry.

The summit also fosters collaboration between pharmaceutical companies, research institutions, and healthcare professionals to accelerate the development of innovative therapies. Participants can explore cutting-edge solutions for enhancing drug bioavailability, stability, and efficacy, while addressing challenges in formulation design and regulatory compliance.

This event in Paris, France provides a unique opportunity to connect with international peers, discover emerging technologies, and contribute to shaping the future of pharmaceutical formulations through innovative drug delivery systems.

Why Attend

Attending the 19th World Drug Delivery Summit offers:

• Networking opportunities – Connect with global experts, researchers, and industry professionals.
• Keynote speakers – Learn from leaders driving innovation in drug delivery and pharmaceutical formulations.
• Oral presentations – Share your research and gain feedback from international peers.
• Poster sessions – Showcase your work to a wide audience and highlight your findings.
• Workshops & interactive sessions – Gain hands-on experience with the latest technologies.
• Panel discussions – Engage in debates on current challenges and future trends.
• CPD/CME credits – Earn professional development recognition for your career advancement.
• Certificate of participation – Receive official documentation of your involvement.
• Collaborative opportunities – Explore partnerships for research, projects, or funding.
• Exposure to cutting-edge technologies – Discover innovations in nanomedicine, targeted delivery, controlled-release systems, and more.

Target Audience

• Pharmaceutical scientists
• Drug formulation experts
• Clinical researchers
• Pharmacologists
• Biotechnologists
• Nanomedicine experts
• Regulatory professionals
• Quality control specialists
• R&D managers
• Academic faculty
• Graduate students
• Industry professionals
• Biotech startups
• Young researchers and fellows
• Pharmacists
• Biomedical engineers
• Medical device experts
• Drug delivery technology developers
• Clinical trial coordinators
• Innovation officers

Sessions and Tracks

Track 01: Advanced Drug Delivery Systems

The development of advanced drug delivery systems is revolutionizing the way drugs are administered and how they interact with the body. These systems are designed to improve therapeutic outcomes by ensuring the precise delivery of drugs to specific sites of action, enhancing bioavailability, and reducing side effects. Key areas of focus include the use of nanocarriers, polymeric systems, liposomes, and micelles. The incorporation of stimuli-responsive platforms that can release drugs in response to environmental factors such as pH, temperature, or light is another promising advancement. These systems allow for targeted and controlled drug release, making treatments more effective, especially in areas such as oncology, cardiovascular diseases, and chronic conditions like diabetes. Innovations in oral, transdermal, and injectable formulations are also key to improving drug stability and patient adherence.
Keywords: Targeted drug delivery, sustained release, nanocarriers, polymeric systems, controlled release, bioavailability enhancement.

Track 02: Nanomedicine and Nanotechnology in Drug Delivery

Nanotechnology is playing a pivotal role in the development of innovative drug delivery systems. The use of nanoparticles, nanoemulsions, and nanocrystals offers numerous advantages in terms of enhanced drug solubility, bioavailability, and targeted delivery. Nanocarriers can be engineered to deliver drugs directly to diseased cells, such as cancer cells, minimizing off-target effects and improving treatment efficacy. Surface functionalization of nanoparticles allows for the attachment of ligands or antibodies, further improving the specificity of delivery. Nanomedicine is also being utilized in gene therapy, immunotherapy, and the treatment of neurological disorders, offering more personalized and efficient therapeutic approaches. Regulatory challenges and the need for rigorous safety evaluation are key considerations as these technologies move from research to clinical application.
Keywords: Nanomedicine, nanoparticles, targeted delivery, nanoemulsions, bioavailability, drug solubility, gene therapy, cancer therapy.

Track 03: Biologics, Gene, and RNA Therapeutics

Biologics, including monoclonal antibodies, peptides, and recombinant proteins, are rapidly becoming central to the treatment of various diseases, particularly cancer, autoimmune disorders, and rare diseases. Gene therapies and RNA-based treatments, such as mRNA vaccines, are also emerging as powerful tools for treating previously untreatable conditions. However, the successful delivery of these biologics and nucleic acids requires innovative drug delivery systems to overcome challenges related to stability, bioavailability, and cellular uptake. Viral and non-viral vectors are commonly used for gene delivery, while lipid nanoparticles have shown promise for mRNA delivery. These approaches require careful design to ensure that the therapeutic payload reaches the target cells while minimizing adverse reactions. Personalized medicine, especially in the context of cancer immunotherapy and genetic disorders, is increasingly reliant on these advanced delivery systems.
Keywords: Biologics, gene therapy, RNA therapeutics, mRNA vaccines, lipid nanoparticles, gene delivery, cancer immunotherapy, personalized medicine.

Track 04: Controlled and Sustained Release Formulations

Controlled and sustained release formulations have become essential in improving the efficacy of long-term therapies and patient adherence. By releasing the active pharmaceutical ingredient (API) in a controlled manner over an extended period, these systems maintain therapeutic drug levels in the bloodstream for longer durations, reducing the need for frequent dosing. This is particularly beneficial for the management of chronic diseases such as hypertension, diabetes, and pain. The use of depot injections, polymeric matrices, and implantable devices has expanded the options for sustained drug delivery. Extended-release formulations are designed to release the drug at a constant rate, while pulsatile release systems can mimic the body’s natural release patterns, providing a more physiological response. Challenges related to formulation stability, release kinetics, and manufacturing are also part of ongoing research in this area.
Keywords: Sustained release, controlled release, depot injections, polymeric matrices, implantable devices, drug release kinetics, patient adherence.

Track 05: Emerging Technologies and Smart Drug Delivery

The integration of emerging technologies into drug delivery systems is opening new possibilities for more precise, efficient, and personalized treatment. Smart drug delivery platforms utilize sensors, wearable devices, and microfluidic systems to monitor and control drug release in real-time. Innovations such as 3D-printed drug delivery systems allow for highly customized medications tailored to individual patient needs, while AI-driven models are being developed to design formulations with greater accuracy. Smart hydrogels, stimuli-responsive carriers, and theranostic systems that combine diagnostics with drug delivery are also becoming more common, particularly in cancer therapy. These systems not only deliver drugs at the optimal dose but also provide monitoring capabilities to ensure the drug is working effectively. This cutting-edge approach to drug delivery has the potential to greatly improve patient outcomes by offering treatments that are more targeted, less invasive, and easier to manage.
Keywords: Smart drug delivery, 3D-printed systems, AI-driven formulation design, microfluidics, smart hydrogels, stimuli-responsive carriers, theranostics.

Track 06: Regulatory, Quality Control, and Translational Aspects

Bringing new drug delivery systems from the laboratory to clinical practice requires navigating complex regulatory landscapes and ensuring that products meet strict quality control standards. This process involves rigorous testing for drug stability, safety, and bioequivalence to ensure that formulations are both effective and safe for patients. Translational research plays a key role in this process, as it bridges the gap between laboratory findings and real-world application. Pharmaceutical companies and researchers must work within regulatory frameworks set by agencies like the FDA and EMA, which oversee the approval of new drug delivery technologies. The track will also cover the importance of good manufacturing practices (GMP) and the steps involved in scaling up formulations for large-scale production. Key challenges in clinical translation, including clinical trial design and patient recruitment, will also be discussed.
Keywords: Regulatory compliance, quality control, GMP, stability testing, bioequivalence, clinical translation, drug approval, manufacturing practices.

Track 07: Pediatric, Geriatric, and Targeted Therapeutics

Formulating drugs for special populations such as pediatric and geriatric patients presents unique challenges. Children and elderly patients have different pharmacokinetics, and their drug dosages and delivery methods must be tailored accordingly. Pediatric formulations require special consideration, including taste masking, ease of administration, and ensuring that the drug delivery system is safe and effective for younger patients. For geriatric populations, the challenge lies in formulating drugs that account for age-related changes in metabolism and organ function. Targeted therapeutics, particularly those utilizing nanotechnology and other advanced delivery systems, offer opportunities to enhance the precision of drug delivery for both pediatric and geriatric patients. This topic will also explore the development of patient-friendly devices such as oral disintegrating tablets, transdermal patches, and liquid formulations that cater to the needs of specific patient groups.
Keywords: Pediatric formulations, geriatric drug delivery, targeted therapeutics, dose optimization, taste masking, patient-friendly devices, nanomedicine.

Track 08: Oral Drug Delivery Innovations

Oral drug delivery remains the most convenient and preferred route for patients, but many drugs face challenges such as poor solubility, low bioavailability, and degradation in the gastrointestinal tract. Recent innovations focus on overcoming these barriers using advanced formulation strategies, including self-emulsifying drug delivery systems, solid dispersions, and mucoadhesive technologies. Nanoparticle encapsulation and polymeric coatings are also used to enhance absorption and protect drugs from enzymatic or acidic degradation. Researchers are exploring ways to design oral systems that allow for controlled release, targeted intestinal absorption, and improved patient compliance, particularly for chronic therapies.
Keywords: Oral drug delivery, bioavailability enhancement, mucoadhesive systems, self-emulsifying formulations, solid dispersions, nanoparticle encapsulation, controlled release.

Track 09: Transdermal and Topical Drug Delivery

Transdermal and topical drug delivery systems provide a non-invasive alternative to oral or injectable routes, allowing for sustained and controlled drug release directly through the skin. Innovations in this area include microneedle patches, iontophoresis, and advanced hydrogel formulations that improve drug penetration and absorption. These systems are particularly valuable for pain management, hormone therapy, and dermatological applications. Efforts are also focused on designing patient-friendly, wearable devices that offer real-time monitoring and feedback, ensuring more precise dosing and enhanced therapeutic outcomes.
Keywords: Transdermal delivery, topical formulations, microneedles, iontophoresis, hydrogel systems, wearable drug delivery, controlled release.

Track 10: Injectable and Parenteral Drug Delivery

Injectable formulations are critical for therapies requiring rapid or precise drug action, such as biologics, vaccines, and high-potency small molecules. Advances in this field include sustained-release injectable depots, prefilled syringes, and liposomal or polymeric formulations for targeted delivery. Stability, sterility, and ease of administration are essential considerations. Researchers are also exploring combination strategies, where injectable carriers are paired with nanoparticles or hydrogels to achieve controlled release, reduce side effects, and improve patient adherence. Injectable delivery systems remain a major area for translational research and clinical innovation.
Keywords: Injectable drug delivery, parenteral formulations, sustained release depots, liposomal delivery, polymeric carriers, biologics, vaccines.

Track 11: Theranostics and Personalized Medicine

Theranostics combines therapeutic and diagnostic capabilities within a single platform, enabling personalized and precise treatment for patients. This includes drug delivery systems that can track, target, and release drugs in response to real-time diagnostic feedback. Applications in cancer therapy, cardiovascular diseases, and neurological disorders are rapidly expanding. Personalized medicine relies on patient-specific factors such as genetics, biomarkers, and pharmacokinetics to design optimal drug formulations. Drug delivery innovations in this area aim to improve therapeutic efficacy, reduce side effects, and provide better patient outcomes.
Keywords: Theranostics, personalized medicine, targeted delivery, biomarker-guided therapy, precision drug delivery, diagnostic-drug systems, patient-specific formulations.

Track 12: Biopharmaceuticals and Protein Delivery

Delivering large biomolecules such as proteins, peptides, and antibodies remains challenging due to their susceptibility to degradation and poor permeability across biological barriers. Advanced drug delivery systems, including nanoencapsulation, PEGylation, and liposomal formulations, have been developed to overcome these challenges. Sustained-release protein formulations, oral protein carriers, and injectable depots are gaining attention for improving stability, bioavailability, and patient adherence. The focus is also on reducing immunogenicity while maintaining therapeutic activity, making protein delivery a critical area of pharmaceutical innovation.
Keywords: Protein therapeutics, peptide delivery, biologics, nanoencapsulation, liposomal carriers, PEGylation, sustained release formulations.

Track 13: Gene Editing and CRISPR Delivery

Gene editing technologies such as CRISPR-Cas9 are revolutionizing therapeutic interventions for genetic disorders. However, efficient and safe delivery of gene-editing components remains a significant challenge. Researchers are developing viral and non-viral delivery systems, lipid nanoparticles, and polymeric carriers to ensure targeted and effective gene editing. Safety, off-target effects, and precise cellular uptake are key factors driving formulation strategies. The potential for treating rare diseases, cancer, and inherited conditions makes this area highly impactful in pharmaceutical research.
Keywords: Gene editing, CRISPR-Cas9, targeted delivery, lipid nanoparticles, polymeric carriers, genetic therapies, off-target reduction.

Track 14: mRNA and Nucleic Acid Therapeutics

mRNA and other nucleic acid therapeutics have transformed modern medicine, particularly with the success of mRNA vaccines for infectious diseases. These therapies require sophisticated delivery systems to protect the fragile nucleic acids from degradation, facilitate cellular uptake, and achieve efficient protein expression. Lipid nanoparticles, polymer-based carriers, and conjugation techniques are widely used to improve stability, bioavailability, and tissue-specific delivery. Researchers are also exploring applications in cancer immunotherapy, rare genetic disorders, and personalized medicine, where tailored nucleic acid delivery can provide highly targeted and effective treatments.
Keywords: mRNA therapeutics, nucleic acid delivery, lipid nanoparticles, polymeric carriers, gene therapy, cancer immunotherapy, personalized medicine.

Track 15: Immunotherapy and Targeted Cancer Therapies

Immunotherapy is one of the most promising areas in modern drug development, aiming to harness the immune system to fight cancer and other diseases. Effective delivery systems are crucial for immunotherapeutics, including monoclonal antibodies, checkpoint inhibitors, cytokines, and CAR-T cells. Nanocarriers, liposomes, and biodegradable polymers are being designed to target tumors selectively while minimizing systemic toxicity. Advances in personalized medicine allow for patient-specific immunotherapy, improving efficacy and safety. Controlled-release formulations also play a significant role in maintaining therapeutic levels and reducing adverse effects.
Keywords: Immunotherapy, targeted cancer therapy, monoclonal antibodies, checkpoint inhibitors, CAR-T cells, nanocarriers, personalized medicine.

Track 16: Wearable and Implantable Drug Delivery Devices

Wearable and implantable devices represent a new era in patient-centric drug delivery, providing real-time monitoring and precise dosing. Smart patches, micro-needles, implantable pumps, and biosensor-integrated devices allow for continuous drug administration and feedback-based adjustments. These systems are particularly useful for chronic conditions such as diabetes, cardiovascular diseases, and pain management. The integration of digital health technologies with drug delivery enhances patient compliance, safety, and treatment outcomes, making these devices increasingly important in pharmaceutical innovation.
Keywords: Wearable drug delivery, implantable devices, micro-needles, smart patches, biosensors, digital health, chronic disease management.

Track 17: Microfluidics and Lab-on-a-Chip Systems in Drug Formulation

Microfluidics and lab-on-a-chip systems offer precise control over formulation processes, allowing the creation of highly uniform nanoparticles, emulsions, and liposomes. These technologies enable rapid screening of drug formulations, optimization of delivery parameters, and scalability for industrial production. Microfluidic platforms are also used for personalized medicine, where patient-specific formulations can be tested in vitro before clinical application. Their potential for cost-effective, high-throughput, and reproducible drug delivery solutions makes microfluidics a rapidly growing field in pharmaceutical sciences.
Keywords: Microfluidics, lab-on-a-chip, nanoparticle synthesis, high-throughput formulation, liposomes, personalized drug delivery, emulsion systems.

Track 18: 3D Printing in Pharmaceutical Formulations

3D printing has introduced the possibility of producing highly personalized drug formulations tailored to individual patient needs. This technology allows for precise control over drug dose, release profiles, and combination therapies in a single dosage form. Applications include oral tablets, implants, transdermal patches, and scaffold-based drug delivery systems. By integrating 3D printing with advanced drug carriers such as hydrogels and nanoparticles, researchers can design complex structures that offer controlled and targeted release. This approach is particularly valuable for patients with rare diseases or specific therapeutic requirements.
Keywords: 3D printing, personalized medicine, controlled release, implantable systems, hydrogels, oral formulations, transdermal patches.

Track 19: Orphan Drugs and Rare Disease Drug Delivery

Formulating drugs for rare diseases presents unique challenges due to small patient populations and complex pharmacological requirements. Advanced delivery systems are critical for achieving therapeutic efficacy while minimizing side effects. These formulations often involve nanocarriers, sustained-release systems, and targeted delivery to ensure maximum benefit for patients with limited treatment options. Regulatory guidance, patient-centric design, and formulation scalability are important considerations in this field. Innovations in this area are helping bridge the gap between research and clinical application for rare and orphan diseases.
Keywords: Orphan drugs, rare disease therapies, targeted delivery, nanocarriers, sustained-release systems, patient-centric design, formulation scalability.

Track 20: Pharmacokinetics and Drug Absorption Optimization

Optimizing pharmacokinetics and drug absorption is essential to ensure that therapeutic agents reach their intended targets efficiently. Strategies include enhancing solubility, improving permeability, and reducing first-pass metabolism. Advanced formulations such as lipid-based carriers, nanoemulsions, solid dispersions, and polymeric systems are commonly used to improve absorption and bioavailability. These approaches are critical for oral, transdermal, and injectable drugs, particularly for compounds with poor solubility or stability. Understanding pharmacokinetic principles allows researchers to design more effective and patient-friendly therapies.
Keywords: Pharmacokinetics, drug absorption, bioavailability, nanoemulsions, lipid-based carriers, polymeric systems, solubility enhancement.

Track 21: Exosome-Based Drug Delivery

Exosomes are naturally occurring extracellular vesicles that have emerged as a promising vehicle for drug delivery. Their ability to transport proteins, nucleic acids, and small molecules across biological barriers makes them highly efficient carriers for targeted therapies. Researchers are exploring their use in cancer therapy, neurodegenerative diseases, and gene therapy. Exosomes are biocompatible, have low immunogenicity, and can be engineered to enhance specificity and therapeutic efficacy. Techniques for large-scale production, purification, and drug loading are currently under development, creating new opportunities for precision medicine.
Keywords: Exosome delivery, targeted therapy, gene therapy, neurodegenerative diseases, cancer therapy, biocompatible carriers, extracellular vesicles.

Track 22: Combination Drug Delivery Systems

Combination drug delivery involves the simultaneous administration of multiple drugs using a single delivery system. This approach can enhance therapeutic outcomes, reduce drug resistance, and improve patient adherence. Advanced carriers such as polymeric nanoparticles, liposomes, and hydrogel systems are being developed to deliver synergistic drug combinations with controlled release profiles. Applications include oncology, infectious diseases, and chronic conditions where multiple mechanisms of action are required. Optimizing the ratio and release kinetics of combined drugs is a key focus in formulation research.
Keywords: Combination therapy, polymeric nanoparticles, liposomes, hydrogel systems, controlled release, synergistic drugs, oncology therapy.

Track 23: Imaging-Guided Drug Delivery

Imaging-guided drug delivery integrates diagnostic imaging techniques with drug administration to enhance precision and monitor therapeutic response in real-time. Techniques such as MRI, PET, and fluorescence imaging can track drug distribution, accumulation, and target engagement. This approach allows for optimized dosing, reduced side effects, and better treatment outcomes. It is particularly valuable in cancer therapy, cardiovascular interventions, and targeted delivery of biologics. Advancements in nanocarriers and contrast agents are making imaging-guided delivery increasingly effective and patient-friendly.
Keywords: Imaging-guided delivery, MRI, PET, fluorescence imaging, nanocarriers, targeted therapy, real-time monitoring.

Track 24: Microbiome-Based Drug Delivery

The human microbiome plays a crucial role in health and disease, and microbiome-based drug delivery is an emerging field that leverages this interaction. Formulations are designed to deliver therapeutics directly to the gut microbiota or modify microbial composition to treat diseases. Probiotics, prebiotics, and microbial metabolites can be encapsulated in nanoparticles or hydrogel systems for controlled release. Applications include gastrointestinal disorders, metabolic diseases, and immunotherapy. Understanding host-microbiome interactions is essential for designing effective and safe delivery systems.
Keywords: Microbiome drug delivery, probiotics, prebiotics, gut-targeted therapy, nanoparticles, hydrogel carriers, immunotherapy.

Track 25: CRISPR-Cas9 and Gene Editing Delivery

Delivering CRISPR-Cas9 components safely and effectively is essential for the success of gene-editing therapies. Advanced carriers such as lipid nanoparticles, viral vectors, and polymeric nanoparticles are designed to transport CRISPR systems to specific cells while minimizing off-target effects. Applications include treatment of genetic disorders, cancer, and viral infections. Research focuses on optimizing delivery efficiency, cellular uptake, and transient expression to achieve therapeutic outcomes while ensuring patient safety.
Keywords: CRISPR-Cas9 delivery, gene editing, lipid nanoparticles, polymeric carriers, viral vectors, targeted gene therapy, off-target reduction.

Track 26: Artificial Intelligence and Machine Learning in Drug Delivery

Artificial intelligence and machine learning are increasingly applied to design and optimize drug delivery systems. These technologies allow researchers to predict drug behavior, optimize formulations, and reduce experimental costs and timelines. AI can model drug release kinetics, nanoparticle stability, and interactions with biological systems. Machine learning algorithms are also used to personalize therapies, identify optimal drug combinations, and enhance targeted delivery. Integration of AI in pharmaceutical formulation is accelerating the development of next-generation therapeutics.
Keywords: Artificial intelligence, machine learning, drug formulation, targeted delivery, predictive modeling, personalized medicine, nanoparticle optimization.

Track 27: Hydrogel-Based Drug Delivery

Hydrogels are highly versatile polymeric networks capable of encapsulating a wide range of therapeutic agents. They offer controlled and sustained release, biocompatibility, and responsiveness to environmental stimuli such as pH, temperature, or enzymes. Hydrogels are being used for wound healing, tissue engineering, cancer therapy, and localized drug delivery. Smart hydrogel systems allow precise drug release based on disease-specific triggers, enhancing treatment efficacy and patient safety. Their combination with nanoparticles or biologics further broadens their potential applications.
Keywords: Hydrogels, smart delivery systems, controlled release, tissue engineering, cancer therapy, biocompatible carriers, stimuli-responsive systems.

Track 28: Targeted Oral and Gastro-Resistant Formulations

Targeted oral drug delivery and gastro-resistant formulations are designed to deliver drugs to specific regions of the gastrointestinal tract, enhancing absorption and therapeutic effectiveness. Coating technologies, pH-sensitive polymers, and enteric capsules protect the drug from degradation in the stomach while enabling release in the intestines. This approach is particularly beneficial for drugs with poor solubility, narrow absorption windows, or sensitivity to gastric conditions. Optimization of release kinetics and drug stability is crucial for achieving desired therapeutic outcomes.
Keywords: Targeted oral delivery, gastro-resistant formulations, enteric coatings, pH-sensitive polymers, controlled release, enhanced absorption, gastrointestinal targeting.

Market Analysis Report

The global drug delivery systems market is experiencing rapid growth and is projected to expand from approximately USD 50 billion in 2025 to over USD 105 billion by 2035, with a compound annual growth rate of around 7–8%. This growth is primarily driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer, which demand advanced, patient-friendly, and efficient drug delivery solutions. Innovations in oral, transdermal, injectable, and inhalation systems, along with the increasing adoption of biologics, gene therapies, and personalized medicine, are reshaping the pharmaceutical landscape. Technological advancements, including nanocarriers, lipid nanoparticles, hydrogel systems, and smart delivery devices, are further enhancing the precision, efficacy, and safety of therapeutics.

The market is also benefiting from emerging trends such as targeted delivery, smart and wearable devices, combination therapies, and theranostics, which integrate diagnostic and therapeutic functions in a single platform. Advanced drug carriers are enabling controlled and sustained release, improved bioavailability, and reduced side effects, while AI and machine learning are increasingly being applied for predictive formulation design, personalized therapies, and optimization of drug delivery systems. Regions such as North America and Europe currently dominate the market due to established healthcare infrastructure and regulatory frameworks, while Asia-Pacific is emerging as a high-growth region driven by increasing healthcare expenditure, population aging, and rising chronic disease burden.

Despite the growth opportunities, the market faces challenges including high research and development costs, complex regulatory requirements, and affordability issues in emerging economies. Companies investing in innovative technologies such as nanomedicine, gene/RNA delivery platforms, implantable and wearable devices, and patient-centric formulations are expected to gain a competitive advantage. By 2035, the drug delivery market will likely double, offering significant opportunities for pharmaceutical companies, biotech startups, academic researchers, and healthcare providers to develop next-generation therapeutics that improve patient compliance, safety, and overall treatment outcomes.

Global Associations and Societies

• American Association of Pharmaceutical Scientists (AAPS)
• International Society for Drug Delivery Systems (ISDDS)
• European Society for the Study of Drug Delivery (ESSDD)
• Controlled Release Society (CRS)
• International Pharmaceutical Federation (FIP)
• American Society for Nanomedicine (ASNM)
• Society for Biomaterials (SFB)
• British Pharmaceutical Society (BPS)
• International Society for the Advancement of Material and Technology for Drug Delivery Systems (ISAMT)
• Asian Association of Pharmaceutical Sciences (AAPS-Asia)

Participation Benefits:

• Explore the latest innovations and research in drug delivery systems and pharmaceutical formulations
• Meet global experts, researchers, and healthcare professionals in the field
• Present your research on an international platform
• Earn CME and CPD credits for professional development
• Attend interactive workshops and scientific sessions
• Receive an official certificate of participation
• Build and expand your professional network
• Enhance your qualifications and career profile
• Discover novel drug delivery technologies and therapeutic strategies
• Learn about cutting-edge approaches in targeted delivery, nanomedicine, and controlled-release systems
• Visit exhibitor booths showcasing the latest pharmaceutical technologies
• Complimentary breakfast, tea, and coffee during the conference
• Digital DOI number for your published abstract
• Official certificate including your abstract title

Registration Options:

Academic Registration:

• University professors, lecturers, and researchers
• Postdoctoral fellows and research scientists
• Graduate and PhD students presenting research
• Healthcare professionals focusing on clinical or pharmaceutical research

Business Registration:

• Pharmaceutical industry representatives and executives
• Biotechnology and medical device company professionals
• Research and development managers in private companies
• Corporate delegates exploring collaborations, partnerships, or product promotion

Student Registration:

• Undergraduate, graduate, and doctoral students in biomedicine, pharmacy, and related disciplines
• Provides access to selected sessions, workshops, and poster presentations
• Gain exposure, learn from experts, and enhance academic knowledge

Virtual Registration:

• Attend the conference online from anywhere in the world
• Includes live streaming of sessions, interactive Q&A, and access to recorded presentations
• Ideal for delegates unable to attend in person while still earning CME/CPD credits

Accreditation Information:

The 19th World Drug Delivery Summit in Paris, France, scheduled for January 29–30, 2026, will be officially accredited for Continuing Medical Education (CME) and Continuing Professional Development (CPD) points. The scientific program, including keynote lectures, oral presentations, panel discussions, and workshops, will undergo review and approval by internationally recognized accreditation authorities to ensure compliance with global educational and clinical standards.

Participants attending the full two-day summit will be eligible to earn 15–20 CME/CPD credits, depending on session attendance and participation in accredited learning activities. Each registered delegate will receive an official certificate of participation specifying the number of accredited hours earned. This accreditation highlights the summit’s commitment to promoting high-quality, evidence-based pharmaceutical education.

By participating, attendees will enhance their knowledge of drug delivery systems, pharmaceutical formulations, nanomedicine, and clinical applications, contributing to professional excellence and innovation in pharmaceutical sciences.

Abstract Submission:

Submit your research, case studies, or findings to the 19th World Drug Delivery Summit and share your work with global experts. All abstracts undergo a peer-review process for presentation approval, providing international recognition in pharmaceutical sciences and drug delivery research.

Submit Your Abstract Here:https://drugdeliveryeurope.pharmaceuticalconferences.com/abstract-submission.php
Register & Book Your Slot: https://drugdeliveryeurope.pharmaceuticalconferences.com/registration.php

Accepted abstracts will be published in the conference proceedings in the summit’s supporting journal, ensuring global visibility and recognition for your research. The review process typically takes 2–3 working days.

For Inquiries
If you have any questions regarding the 19th World Drug Delivery Summit, including abstract submissions, registration, or participation, please reach out to us:

Email: contact@speakermeeting.com
WhatsApp: +44 28 8009 0005

Our team will respond promptly to assist you with all your conference-related queries and provide the necessary support to ensure a smooth participation experience.

Past Conference Report

Drug Devilvery 2025

Welcome to the 18th World Drug Delivery Summit , scheduled to take place on September 19-20, 2025, in Paris, France. This premier event will bring together leading researchers, scientists, healthcare professionals, and industry pioneers from around the globe to explore the latest advancements in drug delivery systems.

Themed "Smart Drug Delivery Systems: Innovations in Controlled Release", this summit aims to showcase groundbreaking research and cutting-edge technologies that are transforming the field of drug delivery. From intelligent materials and stimuli-responsive systems to precision-targeted therapies, the conference will provide a platform to discuss novel approaches that enhance therapeutic efficacy and patient outcomes.

Drug Delivery 2025 offers an excellent opportunity for participants to engage in insightful discussions, share their expertise, and collaborate on solutions to current challenges. The program will feature keynote presentations, interactive workshops, and networking sessions designed to foster meaningful connections and inspire innovation.

Join us in Paris for this exceptional event as we explore the future of drug delivery and its potential to revolutionize healthcare. We look forward to welcoming you to an unforgettable experience at Drug Delivery 2025!